PARIS, April 29, 2016 /PRNewswire/ -- Sanofi, a global and diversified healthcare leader, reports results for the first quarter of 2016. Jérôme Contamine, Chief Financial Officer of Sanofi, comments on the Group's Q1 results and guidance for the rest of the year.

Watch video interview and read transcript:

http://eurobusinessmedia.com/ceo-direct/sanofi/q1-2016-results-interview-with-cfo-jerome-contamine?utm_source=ceo-direct&utm_medium=wire

Topics covered in the interview include:

• Q1 highlights
• Specialty Care
• Dengvaxia®
• Diabetes
• Consumer Healthcare
• Venezuela
• Outlook

About Sanofi

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sanofi-q1-2016-results-300260009.html

SOURCE Sanofi